Ayush Ministry and DBT announce clinical study on Ayurveda as adjunct therapy for TB
On World TB Day, 24 March 2026, the Ministry of Ayush and the Department of Biotechnology announced a collaborative 'Clinical Study on Ayurveda as an Adjunct Therapy for Tuberculosis' at Vigyan Bhawan, New Delhi.
Summary
On World Tuberculosis Day, 24 March 2026, the Ministry of Ayush and the Department of Biotechnology (DBT), Ministry of Science & Technology, formally announced a collaborative clinical study titled 'Clinical Study on Ayurveda as an Adjunct Therapy for Tuberculosis'. The joint announcement at Vigyan Bhawan, New Delhi, was made by Dr. Jitendra Singh, Minister of State (Independent Charge) for Science and Technology, and Prataprao Jadhav, Minister of State (Independent Charge) for Ayush. The study aims at evidence-based integration of traditional Ayurveda with modern anti-TB treatment.
Key facts
- Study
- Clinical Study on Ayurveda as an Adjunct Therapy for Tuberculosis
- Partners
- Ministry of Ayush and Department of Biotechnology
- Announced
- 24 March 2026 (World TB Day), Vigyan Bhawan
- By
- Dr. Jitendra Singh and Prataprao Jadhav
- Role of Ayurveda
- Adjunct (add-on) to standard anti-TB treatment
Practice MCQs 2 questions
The 'Clinical Study on Ayurveda as an Adjunct Therapy for Tuberculosis', announced on World TB Day 2026, is a collaboration between the Ministry of Ayush and:
Show answer
Correct answer: C — Department of Biotechnology
The study is a collaboration of the Ministry of Ayush and the Department of Biotechnology (DBT), Ministry of Science & Technology.
In the Ayush–DBT TB study announced in March 2026, Ayurveda is being tested as:
Show answer
Correct answer: D — An adjunct (add-on) to anti-TB treatment
The study evaluates Ayurveda as an adjunct therapy alongside standard anti-TB treatment, not as a replacement.